Cargando...
The Cost-Effectiveness of HLA-B*5701 Genetic Screening to Guide Initial Antiretroviral Therapy for HIV
OBJECTIVE: To evaluate the clinical impact and cost-effectiveness of HLA-B*5701 testing to guide selection of first-line HIV regimens in the United States. DESIGN: Cost-effectiveness analysis using a simulation model of HIV disease. The prevalence of HLA-B*5701 and the probabilities of confirmed and...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2008
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2648845/ https://ncbi.nlm.nih.gov/pubmed/18784465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e3283103ce6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|